Literature, news and videos pertinent to
The Karen Hutton
Neurosciences Program at ICAN
Daily News Update
Selected lung cancer articles—updated daily
Go to Today's UpdateINHERIT EGFR - Studying Germline EGFR Mutations (INHERIT) —ClinicalTrials.gov
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Corsello, S.M., Nagari, R.T., Spangler, R.D. et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nat Cancer (2020) doi:10.1038/s43018-019-0018-6
Chemo-Sensitivity Testing for Lung Cancer:
Dr. Robert Nagourney & Ryan Kuper
News feed below courtesy of MedWorm:
The Karen Hutton Neurosciences Program at ICAN
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.
For more information about this special program, please click on...
We also accept PayPal™
paypal.me/ICANadvocacy
Federal Tax I.D.: EIN 86-0818253